September 12th 2025, 8:00pm
Dr. Josh Sabari and Max Doppelt explore challenges in trial enrollment and the potential of emerging therapies to offer hope for patients diagnosed today.
September 12th 2025, 7:00pm
This guide for newly diagnosed patients provides key information to help you understand your options and have informed conversations with your oncologist.
September 12th 2025, 5:00pm
When I think about standing up to cancer, I cannot separate the words from my own story.
September 12th 2025, 4:00pm
Early-stage gynecologic cancer is confined to its original site and often treatable; diagnosis, surgery, and new therapies improve outcomes.
September 12th 2025, 3:00pm
For patients with advanced non-small cell lung cancer who progressed on two or more prior regimens, THIO with Libtayo elicited positive responses.
September 12th 2025, 1:00pm
Dr. Thomas Jankowski explained that THIO, a telomerase inhibitor, is being studied with Libtayo to help overcome resistance in advanced lung cancer.
September 11th 2025, 9:00pm
This guide is designed to help you understand liver cancer and equip you with the right questions to ask your medical team.
September 11th 2025, 8:36pm
Choosing the right health insurance plan during Open Enrollment can feel overwhelming, but it doesn’t have to be.
September 11th 2025, 8:00pm
Advances are reshaping treatment for small cell lung cancer, with immunotherapy and emerging options offering hope for longer survival and potential cures.
September 11th 2025, 7:00pm
Susan G. Komen is marking a significant milestone in the effort to improve care and outcomes for people facing inflammatory breast cancer (IBC).
Top Breast Cancer Stories from October 2025
New Book Spotlights Cancer in Early Adulthood
Top Gastrointestinal Cancer News: October 2025
Hairy Cell Leukemia Experts Impart Advice on Care and Support